Announcements Trials

Browse Landscape

Phase

Status

Completed 18 Terminated 12 Unknown 5 Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Tongue Neoplasms 1 Sturge-Weber Syndrome 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Port-Wine Stain 1 Peutz-Jeghers Syndrome 1 Neuroendocrine Tumors 1 Neoplastic Processes 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Liver Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Glioma 1 Glaucoma 1 Epilepsy 1 Diffuse Intrinsic Pontine Glioma 1 Carcinoma, Renal Cell 1

Interventions

Cisplatin 9 pembrolizumab 7 Radiosurgery 6 Gemcitabine 6 Paclitaxel 5 Dexamethasone 5 Taxes 4 Carboplatin 4 trametinib 3 ibrutinib 3 Surveys and Questionnaires 3 Standard of Care 3 Radiotherapy 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Lenalidomide 3 Fluorouracil 3 Erlotinib Hydrochloride 3 Blood Specimen Collection 3 Ascorbic Acid 3 venetoclax 2 veliparib 2 tocilizumab 2 pazopanib 2 obinutuzumab 2 naquotinib 2 lenvatinib 2 fludarabine 2 enzalutamide 2 Vemurafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Neoplasms × Everolimus × Clear all

NCT01178151 2015-04-22

EVAMP

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2 Withdrawn

Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Peutz-Jeghers Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡